Related Experiment Videos
[Acute interstitial nephritis following piperacillin]
O Dörner1, C Piper, H P Dienes
1Medizinische Klinik A, Landeshauptstadt Wiesbaden.
Klinische Wochenschrift
|July 3, 1989
Summary
This case study documents the first immunological evidence of acute interstitial nephritis (AIN) caused by Piperacillin. Despite treatment, the patient succumbed to a severe E. coli infection.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Antibiotic-associated adverse drug reactions pose a significant clinical challenge.
- Acute interstitial nephritis (AIN) is a potential complication of various medications, including antibiotics.
- Piperacillin is a widely used beta-lactam antibiotic with a known, albeit less common, risk profile.
Observation:
- A 75-year-old female patient presented with fever, rash, and nonoliguric renal failure 16 days after initiating Piperacillin therapy.
- Renal biopsy confirmed acute interstitial nephritis (AIN) characterized by lympho-plasma-cellular infiltrate.
- A lymphocyte transformation test demonstrated specific lymphocyte reactivity to Piperacillin.
Findings:
- The patient's presentation and biopsy results strongly indicated Piperacillin-induced acute interstitial nephritis (AIN).
- Immunological testing provided direct evidence of a hypersensitivity reaction to Piperacillin.
- Corticosteroid therapy led to clinical and renal function improvement.
Implications:
- This case provides the first immunological documentation of Piperacillin-induced AIN, strengthening the etiological link.
- It highlights the importance of considering AIN in patients presenting with renal failure during Piperacillin treatment.
- The findings underscore the need for vigilant monitoring and prompt diagnosis of drug-induced kidney injury.